The global transjugular intrahepatic portosystemic shunt (TIPS) market was valued at $93.4 million in 2021 and is projected to reach $127.9 million by 2031, growing at a CAGR of 3.2% from 2022 to 2031. TIPS is a minimally invasive procedure used to treat portal hypertension, hepatorenal syndrome, and Budd-Chiari syndrome by creating a shunt between the portal vein and hepatic vein using a stent.
This procedure is performed by interventional radiologists and has become a preferred alternative to surgical shunts due to its lower complication rates and faster recovery time. The growing prevalence of liver diseases, rising obesity rates, and advancements in TIPS devices are key factors driving market expansion.
Key Market Drivers
1. Rising Prevalence of Liver Diseases
Portal hypertension, cirrhosis, and Budd-Chiari syndrome are increasing due to alcohol abuse, obesity, and viral hepatitis.
According to the National Institute on Alcohol Abuse and Alcoholism (2019), 85,688 liver disease deaths occurred in the U.S., with alcohol contributing to ~45% of cases.
The World Obesity Federation predicts 1 billion adults will be obese by 2025, leading to higher rates of fatty liver disease and cirrhosis.
2. Shortage of Organ Donors
Liver transplantation is limited due to donor shortages, making TIPS a critical alternative for managing complications of end-stage liver disease.
3. Technological Advancements in TIPS Devices
Improved stent designs (e.g., covered stents) reduce complications like shunt stenosis.
Minimally invasive techniques enhance patient outcomes and reduce hospital stays.
4. Growing Geriatric Population
Older adults are more prone to liver diseases and portal hypertension, increasing demand for TIPS procedures.
Market Segmentation
1. By Device Type
Stents (Dominant segment due to high demand for durable shunt solutions)
Accessories (Growing due to increased minimally invasive surgeries)
2. By Application
Portal Hypertension (Largest segment, driven by cirrhosis and chronic liver disease)
Budd-Chiari Syndrome (Rare but increasing due to vascular liver disorders)
Others (Hepatorenal Syndrome, Variceal Bleeding)
3. By End User
Hospitals (Leading segment due to high patient volume and advanced facilities)
Specialty Clinics (Fastest-growing due to specialized liver care)
Others (Ambulatory Surgical Centers, Research Institutes)
Regional Analysis
| Region | Market Share (2021) | Growth Trends |
|---|---|---|
| North America | Largest share (~40%) | High prevalence of liver disease, strong healthcare infrastructure, key players |
| Europe | Significant share | Rising alcohol-related liver diseases, government healthcare initiatives |
| Asia-Pacific | Fastest-growing (Highest CAGR) | Increasing obesity rates, improving healthcare access |
| LAMEA | Emerging market | Growing awareness, but limited access in low-income regions |
Challenges and Restraints
❌ High Cost of TIPS Procedures – Limits adoption in developing regions.
❌ Risk of Complications – Hepatic encephalopathy, shunt dysfunction, and infections may deter some patients.
❌ Lack of Skilled Radiologists – Specialized training is required for TIPS placement.
Future Opportunities
✅ Expansion in Emerging Markets – India, China, and Brazil present growth potential due to rising liver disease cases.
✅ Development of Bioabsorbable Stents – Reduces long-term complications.
✅ AI and Robotics in TIPS Placement – Enhances precision and success rates.
Key Market Players
Boston Scientific Corporation
Becton, Dickinson and Company (BD)
Cook Medical Inc.
W.L. Gore & Associates
Terumo Corporation
AngioDynamics Inc.
These companies focus on R&D, strategic partnerships, and regulatory approvals to strengthen market presence.
Conclusion
The TIPS market is set for steady growth, driven by rising liver diseases, obesity, and technological advancements. While high costs and complications pose challenges, innovations in stent technology and minimally invasive techniques offer significant opportunities.
North America leads the market, but Asia-Pacific is the fastest-growing region, fueled by increasing healthcare investments. With improved TIPS devices and expanding applications, the market is poised to enhance liver disease management worldwide.
Key Takeaways (Bullet Points Summary)
✔ Market Size: $93.4M (2021) → $127.9M (2031) | CAGR: 3.2%
✔ Top Drivers: Rising liver diseases, obesity, organ donor shortages, stent advancements
✔ Dominant Segments: Stents (device type), Portal Hypertension (application), Hospitals (end-user)
✔ Fastest-Growing Region: Asia-Pacific (Highest CAGR)
✔ Challenges: High costs, complications, lack of skilled radiologists
✔ Future Trends: Bioabsorbable stents, AI-assisted TIPS, emerging market expansion
